• Home
  • Meetings
  • Online Activities
  • Patient Educcation
  • Resources
  • Industry Information
Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Diabetes in Depth Pittsburgh 2008

Location: Pittsburgh, PA
Date: September 25, 2008

Meeting Overview

Venue:
Hilton Pittsburgh
Primary Audience:
Primary Care
Credits:
8.5 AMA Category 1, AAFP, 8.5 AANP

Diabetes In Depth

Diabetes In Depth is a continuing medical education program designed to meet the education and practice needs of clinicians who regularly diagnose and manage patients with diabetes. At every session, leading experts will provide world-class information on the cormorbidities and risk factors associated with what has become one of the greatest health problems. Earn up to 8.5 AMA PRA Category 1 Credit(s)TM or 8.5 AANP contact hours of continuing education, at no cost.

 

 Presented in collaboration with:
American Diabetes Association

 

Program Objectives

Attend this continuing medical education activity and you will be able to:

  • Incorporate essential clinical management tools, including self-monitoring of blood glucose, medical nutritional therapy, and patient education.
  • Assess treatment strategies and implement patient-specific directed therapies.
  • Analyze the methods and role of intensive glycemic control through early intervention and treatment advancement.
  • Address multifactorial cardiovascular risk in the patient with diabetes, and strategies to manage cardiometabolic risk factors.
  • Explore emerging and new perspectives in the treatment of diabetes.

 

Curriculum Developed by Course Directors:

Ken Fujioka, MD, Division of Endocrinology & Diabetes, Director of the Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, CA
M. Sue Kirkman, MD, Vice President, Clinical Affairs, American Diabetes Association, Alexandria, VA

 

Complimentary Education Materials courtesy of the American Diabetes Association

Attend this program and you will receive important provider and patient materials from the American Diabetes Association that can help your patients understand the cardiometabolic risks associated with diabetes, and help them to better achieve their health goals.

 

This activity is intended for primary care providers currently engaged in patient care.


Special Needs

In accordance with the Americans with Disabilities Act, Pri-Med Institute seeks to make this conference accessible to all. If you have a need which might require special accommodations, please call 877-4PRI-MED or email support@pri-med.com three weeks prior to the meeting.

Marketing Partners

Pri-Med partners with local healthcare associations, managed care organizations, and publications in order to ensure that all practicing clinicians have the opportunity to attend. Pri-Med would like to thank the following partners for this program to date: Aetna, American Academy of Nurse Practitioners, CIGNA HealthCare, and Pennsylvania Medical Society.

Educational Grants

To date, the following organizations have provided educational grants in support of this Pri-Med activity: Abbott , Amylin Pharmaceuticals, Inc. and Eli Lilly and Company, Merck & Co., Inc., and Novo Nordisk Inc..

Session Summary

Following is a recap of the core educational elements from the conference sessions, to help you take what you learned and apply it to your interactions with patients.

View Schedule for:
Thursday, September 25, 2008
8:00 AM-9:15 AM
Prevention and Diagnosis of Type 2 Diabetes

Description:

1. Identify the cascade of factors--including insulin resistance and impaired beta-cell function--that contribute to the pathophysiology of type 2 diabetes. 2. Detail the role of timely lifestyle changes and pharmacotherapy in the prevention of type 2 diabetes.
Lawrence S. Phillips, MD, Professor of Medicine, Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, Atlanta VA Medical Center, Decatur, GA
9:15 AM-10:30 AM
The First Step: Managing Diabetes Through Noninsulin Therapy

Description:

1. Outline the initial treatment options for managing type 2 diabetes in a newly diagnosed patient. 2. Understand the parameters that guide when and how to step up pharmacotherapy in a patient who is not well controlled on monotherapy.
Howard A. Brand, MD, Medical Director, Sound Endocrinology, Stonybrook, NY
10:45 AM-11:30 AM
Workshop 1: Assessment of Special Populations and Risk

Description:

1. Recognize the degree to which ethnicity and age influence how patients approach the diagnosis and management of a chronic illness like diabetes. 2. Apply culturally sensitive principles to diabetes care in Latino, African American, and Asian populations.
Howard A. Brand, MD, Medical Director, Sound Endocrinology, Stonybrook, NY
11:45 AM-1:00 PM
Working Lunch: Insulin Therapy--Best Practices for Use

Description:

1. Understand the strengths and limitations of the different types of insulin products, including rapid-acting analogues, intermediate-acting and long-acting insulins, and premixed insulins. 2. Discuss when and how to initiate insulin therapy in an insulin-naive patient.
Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes, and Metabolic Diseases, Ochsner Clinic Foundation, New Orleans, LA
1:15 PM-2:00 PM
Workshop 2: Insulin Initiation and Intensification

Description:

1. Develop skill in calculating and titrating insulin doses using basal and premixed insulin. 2. Sketch out a scenario that calls for appropriate insulin titration in a patient with type 2 diabetes.
Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes, and Metabolic Diseases, Ochsner Clinic Foundation, New Orleans, LA
2:00 PM-3:15 PM
Dyslipidemia and Hypertension in the Diabetic Patient

Description:

1. Understand the parameters that define the amplified risk posed by these common comorbidities in patients with type 2 diabetes. 2. Apply the most current lipid and HTN management guidelines, with an eye on the specific goals in a patient with diabetes.
Kelly Anne Spratt, FACC , DO, Clinical Associate Professor of Medicine, Director of the Women's Center for Cardiovascular Health, University of Pennslyvania School of Medicine, Philadelphia, PA
3:30 PM-4:15 PM
Workshop 3: Assessment and Management of the Diabetic Foot

Description:

1. Understand how the complications and comorbidities of type 2 diabetes increase the risk of foot ulcers. 2. Learn how to do a comprehensive foot exam and identify "red flags" that warrant referral in high-risk patients.
John Giurini, DPM, Chief, Division of Podiatry, Beth Isreal Deaconess Medical Center, Boston, MA, Member of Harvard Medical Faculty Physicians (HMFP) at Beth Israel Deaconess Med, Harvard Medical School, Boston, MA
4:15 PM-5:30 PM
New Perspectives in the Management of Obesity

Description:

1. Understand how obesity complicates the management of type 2 diabetes and compounds the risk of cardiovascular disease. 2. Detail the initial and "next step" treatment options in managing obesity in your type 2 diabetes patients.
Holly Wyatt, MD, Center for Human Nutrition, University of Colorado Health Sciences Center, Aurora, CO

Accreditation

Credits Type Accreditation Statement Designation Statement
8.5 AMA Category 1 Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 8.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
8.5 AANP Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8.5 contact hour of continuing education , which includes 4.250 hours of pharmacology.

Academic Partner

Pri-Med Institute gratefully acknowledges the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute for serving as academic partners in the review of educational content.

Statement of Independence

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Hilton Pittsburgh
600 Commonwealth Place
Pittsburgh, PA 15222
(412)391-4600
Hilton Pittsburgh web site

Hotel Accommodations

A limited number of rooms have been reserved at the Hilton Pittsburgh. Please call (412)391-4600 by 09/02/2008 and identify yourself as a Diabetes In Depth attendee to receive the discounted rate of $159.

Related CME

September 25, 2008

Featured Activities Format Credits ExpiresStatus
Diabetes In Depth: Dialogues from the Pri-Med Program in PittsburghDialogues2 AMA1
02/18/2010

Additional Meetings

??
Other Recommended Meetings

Pri-Med Access with ACP Washington, DC - August 7, 2009 - August 8, 2009

Washington, DC

Meeting Overview | Register now | Add to my Outlook Calendar

Pri-Med New York 2009 - August 27, 2009 - August 30, 2009

New York, NY

Meeting Overview | Register now | Add to my Outlook Calendar

Diabetes in Depth Tampa 2009 - September 10, 2009

Tampa, FL

Meeting Overview | Register now | Add to my Outlook Calendar